Study on the regularity of drug use of Chinese Medical Code in the treatment of pulmonary fibrosis based on data mining#br#
XIAO Siyao1,2 YU Yang2 XIONG Yimin1,2 LIU Yingfang1,2 ZHANG Shunan2
1.Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China;
2.Department of Traditional Chinese Medicine for Pulmonary Diseases of Respiratory Medicine Center of China-Japan Friendship Hospital National Center for Respiratory Medicine Institute of Respiratory Medicine of Chinese Academy of Medical Sciences National Clinical Research Center for Respiratory Diseases Collaborating Centre for WHO Tobacco Cessation and Respiratory Diseases Prevention, Beijing 100029, China
Abstract：Objective To explore the drug use characteristics and prescription regularity in the treatment of pulmonary fibrosis in Chinese Medical Code. Methods “Lung atrophy” “Pulmonary arthralgia” “dyspnea syndrome” as the key words, the prescriptions about the treatment of pulmonary fibrosis in Chinese Medical Code were searched, and the prescriptions were screened by reading the literatures. Excel 2010 was used to extract the data of the prescriptions and to establish the drug database, SPSS Statistics 20.0 and SPSS Molder 18.0 were used to mine the rules of prescription medication. Results The study finally included 102 prescriptions, 108 Chinese herbs, the total frequency of drugs was 813, and the use drugs with the frequency ≥10% were 24. The core compatibility drugs in the prescription include Radix Glycyrrhizae, Radix Ginseng, Poria, Radix Platycodonis, Bulbus Fritillariae Cirrhosae, Radix Asteris, Flos Farfarae, and so on. Conclusion Taking tonifying lung and spleen as the core, combined with warming or clearing heat, supplemented by relieving asthma, reducing qi, resolving phlegm, relieving cough, and other treatment are the prescription regularity for the treatment of pulmonary fibrosis in Chinese Medical Code.
肖锶瑶1,2 于洋2 熊轶敏1,2 刘莹芳1,2 张纾难2. 基于数据挖掘的《中华医典》中肺纤维化的用药规律研究[J]. 中国医药导报, 2022, 19(5): 159-162.
XIAO Siyao1,2 YU Yang2 XIONG Yimin1,2 LIU Yingfang1,2 ZHANG Shunan2. Study on the regularity of drug use of Chinese Medical Code in the treatment of pulmonary fibrosis based on data mining#br#. 中国医药导报, 2022, 19(5): 159-162.
京公网安备 11010502046598号